GTPBP8 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.137000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.754600E-01
Normal-vs-Stage2
9.376400E-01
Normal-vs-Stage3
6.533000E-01
Normal-vs-Stage4
2.459200E-01
Stage1-vs-Stage2
5.674000E-01
Stage1-vs-Stage3
4.703200E-01
Stage1-vs-Stage4
3.215600E-01
Stage2-vs-Stage3
6.035400E-01
Stage2-vs-Stage4
5.951700E-02
Stage3-vs-Stage4
1.508040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.867800E-01
Normal-vs-AfricanAmerican
7.996000E-01
Normal-vs-Asian
8.032200E-01
Caucasian-vs-AfricanAmerican
5.337400E-01
Caucasian-vs-Asian
7.662600E-01
AfricanAmerican-vs-Asian
5.431200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.867800E-01
Normal-vs-Female
9.230200E-01
Male-vs-Female
1.584180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.592600E-01
Normal-vs-Age(41-60Yrs)
9.521400E-01
Normal-vs-Age(61-80Yrs)
8.692200E-01
Normal-vs-Age(81-100Yrs)
9.564400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.415800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.190400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.607600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.250600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.259200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.327400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.789000E-01
Normal-vs-Daily Drinker
3.968600E-01
Normal-vs-Weekly Drinker
4.336000E-01
Normal-vs-Occasional Drinker
7.392000E-01
Normal-vs-Social Drinker
9.555800E-01
Non Drinker-vs-Daily Drinker
9.436000E-01
Non Drinker-vs-Weekly Drinker
8.699600E-01
Non Drinker-vs-Occasional Drinker
2.457600E-02
Non Drinker-vs-Social Drinker
1.124810E-01
Daily Drinker-vs-Weekly Drinker
8.356000E-01
Daily Drinker-vs-Occasional Drinker
3.861700E-02
Daily Drinker-vs-Social Drinker
1.385750E-01
Weekly Drinker-vs-Occasional Drinker
9.251600E-02
Weekly Drinker-vs-Social Drinker
2.377200E-01
Occasional Drinker-vs-Social Drinker
6.250400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.996370E-01
Normal-vs-Grade 2
1.315860E-02
Normal-vs-Grade 3
1.825700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.348080E-02
Grade 1-vs-Grade 3
6.355700E-02
Grade 1-vs-Grade 4
1.996370E-01
Grade 2-vs-Grade 3
6.557600E-01
Grade 2-vs-Grade 4
1.315860E-02
Grade 3-vs-Grade 4
1.825700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.650600E-01
Normal-vs-NonDiabetic
7.623000E-01
Diabetic-vs-NonDiabetic
9.774600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.416800E-01
Normal-vs-NoPancreatitis
7.961200E-01
Pancreatitis-vs-NoPancreatitis
5.320800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.676200E-01
Normal-vs-N1
9.448800E-01
N0-vs-N1
9.439400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.322800E-01
Normal-vs-TP53-NonMutant
9.574200E-01
TP53-Mutant-vs-TP53-NonMutant
1.830980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
